The expression of P-glycoprotein encoded by the multidrug resistance (MDR1) gene is associated with the emergence of the MDR phenotype in cancer cells. Human MDR1 and its rodent homolog mdr1a and mdr1b are frequently overexpressed in liver cancers. However, the underlying mechanisms are largely unknown. The hepatocarcinogen 2-acetylamino¯uorene (2-AAF) eciently activates rat mdr1b expression in cultured cells and in Fisher 344 rats. We recently reported that activation of rat mdr1b in cultured cells by 2-AAF involves a cis-activating element containing a NFkB binding site located 7167 to 7158 of the rat mdr1b promoter. 2-AAF activates IkB kinase (IKK), resulting in degradation of IkBb and activation of NF-kB. In this study, we report that 2-AAF could also activate the human MDR1 gene in human hepatoma and embryonic ®broblast 293 cells. Induction of MDR1 by AAF was mediated by DNA sequence located at 76092 which contains a NF-kB binding site. Treating hepatoma cells with 2-AAF activated phosphoinositide 3-kinase (PI3K) and its downstream eectors Rac1, and NAD(P)H oxidase. Transient transfection assays demonstrated that constitutively activated PI3K and Rac1 enhanced the activation of the MDR1 promoter by 2-AAF. Treatment of hepatoma cells with 2-AAF also activated another PI3K downstream eector Akt. Transfection of recombinant encoding a dominant activated Akt also enhanced the activation of MDR1 promoter activation by 2-AAF. These results demonstrated that 2-AAF up-regulates MDR1 expression is mediated by the multiple eectors of the PI3K signaling pathway.
Introduction
Multidrug resistance (MDR), a major obstacle in cancer chemotherapy for many human malignancies, is characterized by the overexpression of a family of membrane proteins called P-glytoproteins (P-gps) that are encoded by the MDR gene family (Borst, 1997; Ling, 1997) . P-gps are a group of 170 kDa proteins with multiple transmembrane domains and two intracellular ATP binding domains. It is generally believed that the overexpressed P-gp serves as an eux pump by expelling antitumor agents from the cytoplasm and thus reduces intracellular drug concentrations to sublethal levels. In humans, there are two MDR genes: MDR1, which is involved in transport of many antitumor agents, and MDR2 which is involved in phospholipid transport. There are three mdr genes in rodents: mdr1a and mdr1b encode amino acid sequences closely related to that of MDR1 and function as multidrug transporters, whereas mdr2 or mdr3, like MDR2, functions as phospholipid transporter.
MDR1 expression is frequently elevated in many human malignancies (Deng et al., 2001a) including hepatocellular carcinoma (HCC) (Ng et al., 2000; Soini et al., 1996; . Likewise, enhanced expression of mdr1a and mdr1b are observed in rodent HCC induced by various hepatocarcinogenetic programs (Fairchild et al., 1987; Teeter et al., 1990 Thorgeirsson et al., 1987) . In rats, hepatic expression of mdr1b can be induced by the hepatocarcinogen 2-acetylamino¯uorene (2-AAF) Thorgeirsson et al., 1987) . 2-AAF is a model hepatocarcinogen used in many experimental liver cancer studies (Verna et al., 1996) . In treated animals, metabolites of 2-AAF react with DNA and the contents of DNA adducts are found in the target tissues, liver and bladder, but tumor formation is proportional to dose only in the liver (Poirie et al., 1991) . In addition, it is believed that 2-AAF also induces liver cancers through nongenotoxic eects such as promoting cell proliferation (Verna et al., 1996) . However, the mechanisms underlying hepatic MDR gene activation by 2-AAF remain largely unknown.
Using the rat hepatoma cell line H4-II-E, we previously demonstrated that a NF-kB site located at 7159 nt of the mdr1b promoter is involved in the activation of mdr1b by growth factors (insulin and insulin-like growth factors) (Zhou and Kuo, 1997) . Recently, we reported that the same NF-kB site is also involved in the activation of mdr1b expression in H4-II-E cells after exposure to 2-AAF. 2-AAF upregulates mdr1b through the generation of reactive oxygen species (ROS), activation of IkB kinase (IKK), and degradation of IkBb, resulting in activation of NF-kB (Deng et al., 2001a) .
Although human MDR1 and rat mdr1b are very similar in the their coding regions, their upstream regulatory sequences are quite dierent (Shen et al., 1990; Zhou et al., 1996) . Moreover, the proximal NFkB binding site that involved in the carcinogenregulated rat mdr1b is not present in the human MDR1 homolog. Thus, it was not clear whether 2-AAF would induce human MDR1 expression in hepatoma cells; and if so, whether the mechanism(s) of induction were similar to that of rat mdr1b. In this communication, we demonstrated that treating human hepatoma HepG2 cells or human embryonic kidney 293T cells with 2-AAF or its metabolite N-acetoxy-2-acetylamino¯uorene (AAAF) induced MDR1 expression. Transient transfection assays demonstrated that the induction of MDR1 expression is mediated by an NF-kB activating signal that requires a NF-kB binding site located distal to the MDR1 promoter. We further demonstrate that the induced NF-kB signaling by 2-AAF involved activation of phosphoinositide 3-kinase (PI3K) through its eectors Rac and NADPH oxidase eectors that generate ROS. We also demonstrated the activation of another PI3K downstream eector, PKB/ Akt, in the 2-AAF-treated cells. Our results reveal a conserved mechanism of carcinogen-activation of MDR1 expression between human and rodent that involves activation of NF-kB signaling by PI3K and its eectors.
Results

2-AAF and AAAF up-regulate human MDR1 mRNA expression
We (Deng et al., 2001a) and others (Silverman and Hill, 1995; Fairchild et al., 1987; Thorgeirsson et al., 1987) have previously demonstrated that expression of rat mdr1b in hepatoma cells can be induced by 2-AAF. To investigate whether 2-AAF could induce human MDR1 expression in cultured cells, we treated HepG2 cells with AAAF at concentrations ranging from 10 to 40 mM for 8 h. AAAF is an active metabolite of 2-AAF. Total RNA was prepared from the treated cells. MDR1 mRNA levels were determined by the RNase protection assay. Figure 1a shows 2.2-to 3.2-fold induction of MDR1 mRNA in HepG2 cells by AAAF at this concentration range. Time-dependent induction of MDR1 mRNA expression by 100 mM of 2-AAF was seen in 293 cells (Figure 1b) . Levels of MDR1 mRNA induction by 2-AAF were lower in 293 cells than that induced in HepG2 cells (Figure 1a ). This may be because metabolite AAAF is a more potent inducer than 2-AAF (Deng et al., 2001a) . Alternatively, levels of inducibility of MDR1 expression may dier among dierent cell lines. Nonetheless, these results demonstrated that expression of human MDR1 in cultured cells can be induced by 2-AAF and its metabolite.
Upregulation of human MDR1 expression by AAF is mediated by the distal NF-kB sequence
To determine whether upregulation of MDR1 expression by 2-AAF is regulated by NF-kB signal, we ®rst searched whether there are NF-kB binding sequences located upstream of the human MDR1 promoter. A human BAC clone (CTB-60P12, GenBank access No. AC002457) containing 140 828 bp of human MDR1 5' upstream sequence is present in the human genome database. Using the transcription factor binding site prediction program TESS (University of Pennsylvania), we found that there is a NF-kB binding site 76092 GGGAATTCT located upstream from the MDR1 transcription starting site. A series of reporter plasmids with and without this site were constructed (Figure 2 ). These recombinant DNAs were transfected into 293 cells followed by treatment with 100 mM 2-AAF for 24 h. We used 293 cells for transfection because they have a good transfection eciency (*50%) using the lipofectamin transfection kit (GIBCO/BRL), in contrast to HepG2 which only provided less than 2% of eciency (not presented). As shown in Figure 2 , 76228 H.MDRluc, which contains an NF-kB binding site increased 2 ± 4-fold (three experiments) reporter expression by 2-AAF induction as compared with the untreated control. 76042H.MDRluc and 72930H.MDRluc which do To investigate whether the
76092
GGGAATTCT NFkB binding site was indeed involved in the induced reporter gene expression by 2-AAF, we inserted DNA containing sequence 76228 to 76042 nt of the MDR1 into pGL3-promoter vector (Promega) which contains a basal promoter from SV40. Recombinant DNA containing mutant NF-kB site ( 76092 GGGAGGGCT) was similarly constructed. Figure 2 shows that mutation at the NF-kB binding site abolished the induction of reporter expression by 2-AAF, whereas the wild-type construct remained responsive to the induction by the carcinogen.
We also performed a co-transfection assay with expression recombinant encoding dominant negative NF-kB inhibitors, IkBa or IkBb. Induction of reporter expression by 2-AAF was abolished; whereas cotransfection with mutant IkBa (IkBa (AA)) did not suppress the induction of expression by 2-AAF (data not shown). To demonstrate that NF-kB can bind to the promoter of MDR1 gene directly, we performed electrophoretic mobility shift assay (EMSA). 293 cells were treated with 100 mM 2-AAF for various time intervals. Nuclear extracts were prepared. As shown in Figure 3 , increased DNA binding activity became noticeable at 2 h, reaching a maximum at 3 ± 4 h post-treatment. The binding was veri®ed by virtue that the complex formation was diminished by the addition of anti-p65 and p-50 antibodies (Figure 3 , lanes 11 and 12) but not by pre-normal serum (lane 10). While the same anti-p50 antibody (but not anti-p65 antibody) could supershift the rat mdr1b NF-kB binding complex (Deng et al., 2001a) , we were unable to detect supershift of the complex by this antibody. These results suggest that p65 and p50 heterodimer is involved in the NF-kB-mediated 2-AAF activation of MDR1 expression.
2-AAF activates IKK in human hepatoma cells
NF-kB is a dimeric transcription factor consisting of p65 and p50. In unstimulated cells, NF-kB is sequestered in cytoplasm by binding to an IkB family, notably IkBa or IkBb. Upon activation, IkB proteins are phosphorylated by IKK, resulting in ubiquitinylation and protein degradation. Degradation of IkB releases NF-kB which then translocates to the nucleus and activates its target genes. IKK contains two catalytic subunits, IKKa and IKKb, and a regulatory subunit IKKg. Activation of IKK by various stimulants depends upon phosphorylation of the catalytic subunits, particularly IKKb (Karin, 1999) . To investigate whether treatment of 2-AAF activates IKK in human cells, we used an in vitro kinase assay to measure IKKb activity in HepG2 cells treated with 2-AAF, because IKKb activity is more strongly induced than IKKa by most extracellular stimuli (Rothwarf and Karin, 1999) . Figure 4a shows a time-dependent IKK induction by 2-AAF. The induction of IKKb activity was not due to elevation of IKKb protein levels, because Western blotting analysis with anti-IKKb antibody failed to detect increases in IKKb protein levels. Similar result was obtained in experiments using 293 cells. To complement these studies,¯ag-tagged wild-type (wt) IKKb and its kinase-de®cient mutant (Zandi et al., 1998) were transfected into 293 cells. Twenty-four hours later, cells were treated with 2-AAF for 3 h. FlagIKKb was immunoprecipitated by anti-¯ag antibody and the kinase activity was assayed using GST-IkBa as a substrate. 2-AAF incuced 5.5-fold IKKb activity in the wt-IKKb transfected cells. There was no signi®cant change in activity in the mutant IKKb- 
values of three determinations
Figure 3 2-AAF activates DNA binding activity of NF-kB. 293 cells were treated with 100 mM 2-AAF for dierent times as indicated and nuclear extracts were subjected to gel mobility shift assay (lanes 2 ± 8; lane 1, no nuclear extract). The binding speci®city was determined by co-incubation with normal rabbit serum (lane 10), anti-p65 (lane 11), or anti-p50 (lane 12) antibodies. This ®gure is an example of two separate experiments using two dierent batches of anti-p65 and p50 antibodies transfected cells (Figure 4b ). These results, collectively, strongly suggest that 2-AAF activation of NF-kB through the induction of IKK activities.
Activation of PI3K by 2-AAF
Several mechanisms have been proposed for the activation of IKK complex in cultured cells exposed to various cytotoxic agents (Rothwarf and Karin, 1999) . Reddy et al. (1997) and Sizemore et al. (1999) reported that PI3K plays a role in interleukin-1-mediated activation of NF-kB. To investigate whether PI3K also plays a role in activation of NF-kB by 2-AAF, we ®rst determined whether 2-AAF could activate PI3K. Extracts of HepG2 cells treated with AAAF for various times were assayed for PI3K activity by using phosphatidylinositol as a substrate. As shown in Figure 5 , induction of PI3K activity can be seen 20 min after the addition of AAAF, reaching a plateau at around 40 to 60 min and slowly declining thereafter. These results demonstrate that AAAF indeed can activate PI3K in hepatoma cells. Attempts to use PI3K inhibitors, wortmannin and LY194002, to determine whether these inhibitors could suppress the induction failed, because these inhibitors by themselves were very toxic to the cells (data not shown).
The PI3K family can be classi®ed into three groups, depending upon their subunit combinations and substrate speci®cities (Vanhaesebroeck et al., 1997; Domin and Water®eld, 1997) . Among these, classes IA and IB PI3K are the best characterized. Class IA PI3K, which consists of PI3Ka, PI3Kb, and PI3Kd, contains a p110 catalytic subunit (p110a, p110b and p110d, respectively) and a p85 or p55 regulatory subunit. Class IB PI3K consists of PI3Kg containing a p110g catalytic subunit and a p101 (but not p85) regulatory adaptor. Cotransfecting plasmid encoding a PI3K catalytic variant, mp110, increased 4.6-fold of the MDR1 reporter expression in the absence of AAF; and 167-fold increase in the presence of AAF (three experiments). The mp110 recombinant contains the N-terminal myristoylation sequence of pp60 c-sac for membrane targeting. In transient co-expression assays, mp110 exhibited 410-fold increased activities in the activation of the known eectors of PI3k, p70 S6 kinase and Akt, compared with the wt p110 (Klippel et al., 1994) . The observations of such remarkable increase of MDR1 reporter expression in the presence of AAF suggest that the carcinogen could potentiate the membrane-targeted p110 in the activation of MDR1 expression, although the mechanisms of such potentiation remain to be investigated. We also performed co-transfection experiments to determine whether dominant negative PI3K mutants, Dp85 and Dp110g, would alter the induction of reporter expression in response to 2-AAF treatment. The Dp85 construct lacks amino acid residues 478 ± 513 of p85 and functions as dominant negative mutant for PI3Ka, PI3Kb, and PI3Kd. Dp110g lacks 948 ± 981 amino acids of p110 and functions as dominant negative inhibitor for PI3Kg (Cieslik et al., 2001) . As shown in Figure 5 , co-transfection of these dominant negative recombinants did not support the elevated expression of reporter gene, either in the absence or in the presence of 2-AAF ( Figure 6 ). These results support the involvement of PI3K signaling in the regulation of MDR1 expression.
2-AAF activates the small GTP-binding potein Rac
We previously demonstrated that 2-AAF activates NFkB signaling through the generation of reactive oxygen species (ROS). It has been recently shown that growth factor-induced ROS is dependent upon activation of PI3K and the small G-protein Rac . Moreover, it has been demonstrated that Rac-1 protein eciently induce the transcriptional activity of NF-kB by a mechanism that involves phosphorylation of IkBa and translocation of p50/p65 heterodimers to the nucleus (Sulciner et al., 1996; Perona et al., 1997; Montaner et al., 1998) . We thus investigated whether activation of NF-kB signaling by 2-AAF involves the activation of Rac. To this end, we ®rst investigated whether treatment of 2-AAF would activate Rac. Rac is a GTP/GDP exchange protein and activated Rac is associated with GTP. Activated Rac selectively binds the PDB domain of p21-activated kinase (PAK). Activated Rac was subjected to anity pull-down by PAK-1 agarose and assayed by Western blot using anti-Rac antibody (Benard et al., 1999) . Figure 7 is a representative autoradiograph of three independent experiments showing that treatment of 293 cells with 2-AAF activated Rac in a time-dependent manner. We also performed a transient transfection assay to determine whether constitutively active Rac1 (V12rac1) and dominant negative recombinant (N17rac1) would enhance the 2-AAF-induced MDR expression. Figure 8 shows that, in the absence of 2-AAF, co-transfection of the V12rac1 plasmid slightly enhanced MDR1 reporter expression. However, in the presence of 2-AAF, it markedly increased the levels of induction. These results demonstrated that Rac activation is required for optimal activation of NF-kB by 2-AAF. Cotransfection with mutant N17rac1 did not signi®cantly suppress reporter expression, nor did it inhibit the induction of reporter expression by 2-AAF (Figure 8 ). These results suggest that N17rac1 did not exert a dominant negative function in the system, suggesting that additional pathways may be involved in the NFkB-mediated transcription action of MDR1 expression by 2-AAF (see below).
2-AAF activates NADPH oxidase
Rac is an essential component of NADPH-oxidase which generates superoxide. The core enzyme of NADPH oxidase is composed of six subunits: p22 PHOX , p91
PHOX , p40 PHOX , p47 PHOX , p67 PHOX , and Rac (reviewed in Babio, 1999) . In unstimulated cells, these subunits are distributed in the cytoplasmic membrane (p22 PHOX and p91 PHOX ) and in the cytosol (p40 PHOX , p47 PHOX , p67 PHOX , and Rac). Upon stimulation, the cytosolic components translocate to the membrane and assemble with other subunits to form the active oxidase.
To investigate whether 2-AAF activates NADPH oxidase, 293 cell extracts were treated with dierent concentrations of 2-AAF. 2-AAF induces a concentration-dependent increase of superoxide as assayed by the cytochrome c reduction assay (Figure 9 ). Figure 6 Eects of PI3K on expression of MDR1 assayed by transient transfection. 293 cells were co-transfected with plasmids encoding constitutively p110g (mp110), dominant negative mutants (Dp110g,Dp85) or empty vector (pCMV5) as indicated. Cells were either treated with 100 mM AAF or remained untreated. Twenty-four hours later, luciferase activity was determined Figure 7 Time course induction of Rac by 2-AAF. 293 cells were treated with 100 mM 2-AAF for the time intervals as indicated for the time indicated. Activated Rac levels were determined using the PAK-1 PBD agarose assay kit Figure 8 Eects of Rac on MDR1 promoter activity. 293 cells were co-transfected with plasmids encoding activated Rac (V12rac) or mutant Rac (N17rac) or empty vector (pCMV5). Cells were either left untreated or treated with 100 mM 2-AAF. Twenty-four hours later, luciferase activity was determined These results demonstrate that 2-AAF induces superoxide production, indicative of NADPH oxidase activation.
Activation of Akt by 2-AAF
One of the important downstream targets of PI3K is the serine/threonine kinase Akt (Franke et al., 1997) . By stimulation with growth factors or cytotoxic agents, Akt is recruited from the cytoplasm to the plasma membrane and is phosphorylated (Alessi et al., 1997; Stokoe et al., 1997) . Akt has been shown to phosphorylate IKK and up-regulate its kinase activity leading to the activation of NF-kB (Kane et al., 1999; Ozes et al., 1999) but the activation may depend upon cell context (Ozes et al., 2000; Delhase et al., 2000) . To investigate whether Akt is involved in the 2-AAFmediated NF-kB activation, we determine the activation of Akt using anti-phosphorylated Akt antibody. Figure 10 shows Western blot analyses of Akt using anti-phospho-Akt (serine 472) and anti Akt antibodies. Increased levels of phosphorylated Akt were seen in HepG2 cells treated with 100 mM 2-AAF for 1 h and persisted through the 7 h incubation time. Moreover, co-transfection of constitutively activated Akt recombinant plasmid (Akt (DD)) substantially (4120-fold) enhanced the expression of MDR1 reporter construct in the presence of 2-AAF. While co-transfection of the dominant negative (Akt (AA)) also enhanced the 2-AAF-induced expression of the reporter recombinant, but the enhancement was substantially reduced (510-fold). These results suggest that the dominant negative version did not exert the suppressive eect mediated by 2-AAF (Figure 11) , consistent with the involvement of multiple downstream PI3K eects, i.e., Rac/NADPH. Taken together, our results suggest a pathway of PI3K-mediated induction of MDR1 expression by 2-AAF as shown in Figure 12 .
Discussion
Role of NF-kB in regulation of MDR1 expression by 2-AAF.
A number of extracellular stimulants have been shown to enhance the expression of human MDR1 mRNA. Elevated levels of MDR1 mRNA can be transiently induced by serum and mitogen-stimulation (Cornwell Figure 9 Determination of superoxide production in the 2-AAF treatments. 293 cells were treated with dierent concentrations of 2-AAF for 2 h. Production of superoxide was determined. * Denotes statistical signi®cant P50.05, student's t-test, n=3 as compared with untreated control Figure 10 Activation of Akt by 2-AAF. HepG2 cells were treated with 100 mM 2-AAF for the time intervals as indicated. Cell lysates were prepared. Activation of Akt was determined by Western blot using anti-Phospho-Akt (p-Akt) antibody. Western blots using antibodies against Akt and actin are also shown Figure 11 Activation of MDR1 promoter by cotransfection with Akt recombinant plasmids. 293 cells were co-transfected with expression recombinants encoding constitutively activated Akt (Akt(DD)), or dominant negative Akt mutant (Akt(AAA)), or empty vector (pCMV5). Cells were treated with or without 100 mM 2-AAF for 24 h and luciferase activity was determined and Smith, 1993), heavy metals and heat shock (Chin et al., 1990) , the dierentiation agent sodium butyrate (Mickley et al., 1989) , antitumor agents (Chaudhary and Roninson, 1993) and UV irradiation (Uchiumi et al., 1993) . These results suggest that MDR1 is a stressinducible gene. The proximal region of the MDR1 promoter contains several transcription factor recognition sites for transcription upregulation of MDR1 expression. Notably, the NF-Y binding site located at 782 to 773 mediates MDR1 activation by the histone deacetylase inhibitor trichostatin A and sodium butyrate (Jin and Scotto, 1998) . This site, together with its adjacent Sp1 site (756 to 742), are important for the basal (Sundseth et al., 1997) and UV-induced up-regulation of MDR1 expression (Hu et al., 2000) . A CAAT-like site (7120 to 7110) is involved in the upregulation of MDR1 in human drug-resistant HL60/ VCR line (Ogretmen and Safa, 2000) . More recently, it has been reported that a heat responsive element located at 7315 to 7285 region mediates heat induction of the MDR1 promoter (Vilaboa et al., 2000) . All these sequence elements are proximal (within 7350) to the MDR1 promoter region.
The present report describes an NF-kB site located between 76092 that is involved in the upregulation of MDR1 expression by 2-AAF. These results, together with our recent report showing that the NF-kB site located at 7157 of the rat mdr1b promoter is involved in the AAF-mediated upregulation in rat hepatoma cells (Deng et al., 2001a) , demonstrate that the mechanism of regulation of the MDR1 gene family is conserved between humans and rodents. These results also underscore the importance of NF-kB in carcinogen-induced MDR1 gene expression, despite the physical locations of these sites being quite dierent in reference with their respective promoter regions in these two species. Ogretmen and Safa (1999) reported a negative regulation of MDR1 promoter activity by NFkB/p65 and c-Fos transcription factors interacting with the CAAT box of the promoter in MCF-7 cells but not in an Adriamycin-resistant variant. These results suggest that NF-kB may play multiple roles in the regulation of human MDR1 gene.
Deleting DNA sequence from the 76228 HMDRluc construct which contains an NF-kB site did not entirely abolish the induction of reporter expression by 2-AAF (Figure 2 ). This result suggests that there are sequences downstream from 72930 that still participate in the induced expression of MDR1 by 2-AAF. Identi®cation of those downstream cis-activating elements will require systemic deletion analysis of the MDR1 promoter. It is likely that some of the proximal sequence elements mentioned above may contribute to the overall induction of MDR1 expression by 2-AAF, although this remains to be proven.
Role of the PI3K pathway in the regulation of MDR1 gene expression
We recently demonstrated that induction of mdr1b by 2-AAF in rat hepatoma cells involves a ROS-related upregulation of IKK activity (Deng et al., 2001a) . We demonstrate here that treatment of human cultured cells with 2-AAF activates PI3K. Transient transfection assays using constitutively activated and dominant negative PI3K recombinants demonstrate that PI3K is involved in the upregulation of reporter constructs containing MDR1 sequence. Likewise, co-transfection of constitutively activated Akt enhanced the MDR1 reporter activity. These results, together with our previous (Deng et al., 2001a) , are consistent with the notion that PI3K and Akt are upstream signals that activate the 2-AAF-induced NF-kB signal.
In this study, we also demonstrate that 2-AAF activates Rac activity. Transient transfection of constitutively active Rac enhanced MDR1 promoter activity. NADPH oxidase, the enzyme complex that catalyzes the production of ROS, is an eector of Rac and we also demonstrate the induction of superoxide in the 2-AAFtreated cells. These results together with our previous report (Deng et al., 2001a) are most compatible with the This activation pathway is, if not entirely overlapping, complementary to the growth factor-induced mechanism of gene activation and cell proliferation. PI3K and Rac have been shown to play important roles in various aspects of cellular physiology, including cell proliferation, transcriptional regulation, and cytoskeletal remodeling (Schlessinger, 2000; Bar-Sagi and Hall, 2000; Sander et al., 1998; Vanhaesebroeck et al., 1997) . It has been recently reported that PDGFinduced ROS generation is dependent upon PI3K and Rac . Another study showed that activation of NADPH oxidase is essential for sustained activation of the EGFR in EGF-stimulated cell growth (Bae et al., 1997) . Inhibition of superoxide production interferes with the mitogenic activity of Ras (Joneson and Bar-Sagi, 1998) . Our present results implicating that a growth-related signal transduction pathway for the induction of MDR1 expression elicited by 2-AAF is consistent with the previous results showing that MDR1 expression could be induced by growth factors and that the induction was also mediated by the activation of NF-kB signaling (Zhou and Kuo, 1997) . These results underscore the importance of NF-kB in the carcinogen-induced hepatocarcinogenesis and the associated induction of MDR1 expression that may contribute to the intrinsic evolution of drug resistance in liver cancer.
The mechanisms by which 2-AAF activates PI3K remain to be investigated. While class IA PI3K has been implicated in most tyrosine kinase-linked, receptor-mediated signaling events (Bishop and Hall, 2000) , class IB PI3Kg activation is mediated by heterotrimeric G-protein subunits (Stoyanov et al., 1995) . Our preliminary work showed that co-transfection of an activated G12a stimulates the upregulation of MDR reporter expression by 2-AAF, whereas co-transfection with other G-proteins (G11a, Gai2, and Gas1) did not (data not shown). It is likely that 2-AAF activates G12a, which interacts with the catalytic subunit of PI3Kg leading to activation of the MDR1 promoter. However, the role of G-proteins in PI3K-mediated activation of MDR1 must be studied further.
We want to stress that the linear signal transduction pathway presented in Figure 12 may be too simplistic. While as indicated here, PI3K can regulate Rac (Keely et al., 1997; Minden et al., 1995) , it has been suggested that PI3K can also act downstream from Rac (Keely et al., 1997; Roya and Park, 1995) . Rac (three isoforms) are members of the Rho GTPase family (10 members each with multiple isoforms) that belong to Ras superfamily (Bar-Sagi and Hall, 2000; Bishop and Hall, 2000) . About 30 potential eector proteins have been identi®ed that interact with the Rho GTPase (Bishop and Hall, 2000) . Moreover, members of the Ras family cross-talk among dierent eector proteins, depending upon cell context and types of inducers. This produces a complex interactive network of PI3K and Rac and their eectors. While detailed mechanisms underlying how PI3K and Rac regulate MDR1 gene expression in response to carcinogen challenges remain to be elucidated, the present report provides a molecular basis for future studies on how interactions among G-protein, PI3K and various RhoGTPase may induce drug resistance gene expression in liver carcinogenesis.
Roles of PI3K-mediated NF-kB activation pathway in hepatocarcinogenesis
It has been well established that lipid phosphorylation and dephosphorylation play an essential role in the signal transduction of extracellular stimuli into cytoplasm. All PI3Ks are lipid kinases which phosphorylate phosphoinositides at the 3-hydroxyl moities. The product of these reactions, phosphatidylinositol 3,4,5-triphosphate, is second messenger in a variety of signal transduction pathways for cell growth and survival. It is conceivable that activation of the PI3K signal would have an importance in neoplastic transformation and tumor progression by promoting cell proliferation or survival (Hutchinson et al., 2001) .
The demonstration that the human tumor suppressor gene PTEN/MMAC (Hopkin, 1998) which encodes a lipid phosphatase that removes the phosphate from the 3' portion of 3-phosphoinositides (Maehama and Dixon, 1998) highlights the pathophysiological importance of PI3K. Loss of this important tumor suppressor gene product, which modulates PI3K activity, occurs in a variety of human neoplasms (Steck et al., 1997) . Mutational inactivation of PTEN has been detected in human HCC (Fujiwara et al., 2000; Yao et al., 1999; Yeh et al., 1999) . Another phosphoinositide-speci®c phosphatase SHIP has been described (Lioubin et al., 1996; Dame et al., 1996) . SHIP dephosphorylates the 5' position of the inositol ring of phosphoinositides, although the role of this phosphatase in tumor progression remains to be determined. It is possible that activation of this pathway, following the induction of pro-proliferative and/or stress-responsive transcription factors including NF-kB, may induce a battery of genes that play important roles in hepatocarcinogenesis as well as the induction of the drug resistance associated with tumorigenesis. Elucidating the roles of this pathway in the evolution of drug resistance during liver cancer progression may lead to the development of novel strategies for combating this deadly disease.
Materials and methods
Reagents
Reagents were purchased from the following companies: anti-p50 antibodies were purchased from Santa Cruz Biotechnology, Inc. and from Transduction laboratories (San Diego, CA USA), respectively. Anti-phospho-Akt and anti-Akt antibodies from Cell Signaling (Beverly, MA, USA); and AAAF from NCI Chemical Carcinogen Reference Standard Repository (Kansas City, MO, USA). Dual luciferase reporter assay system was from Promega (Medison, WI, USA). All other chemicals were purchased from Sigma (St. Louis, MO, USA). Plasmids-Rat 7245 mdr1b luc was described previously (Deng et al., 2001a) . Human BAC clone (CTB-60P12, GenBank Access No. AC002457) was purchased from Research Genetics (Huntsville, AL, USA). 76228 HMDRluc, 76042.HMDRluc, and 72930HMDRluc were constructed by inserting polymerase chain reaction product between 76228, 76042, and 72930, respectively, and+162, of MDR1 sequences into the KpnI site of pGL2-luciferase vector (Promega). Plasmids Dp85 and Dp110g were obtained from Charles S Abrams (Cieslik et al., 2001 ) and plasmid mp110 was obtained from Klippel et al. (1996) . pEXV-V12rac1 and pEVX-N17rac1 encoding constitutively active and dominant negative Rac1 cDNA, respectively, were described previously (Ridle et al., 1992) and obtained from T Finkel (National Institutes of Health). The kinase-inactive, phosphorylation-de®cient Akt-1 constructs (K179A/T308A/ S473A, or HA-Akt-AAA) behaved as a dominant-negative mutant of Akt (Wang et al., 1999) and constitutively active Akt (HAPKB308D/473D or Akt-DD) (Hutchinson et al., 2001 ) have been described.
Preparation of nuclear extracts and gel mobility shift assay
Nuclear extracts were prepared from the 2-AAF treated 293 cells according to the procedure described previously (Deng et al., 2001a) . Gel mobility shift assay also followed the procedure described in the same article using 32 P-end labeled, double-stranded oligonucleotide containing human MDR1 NF-kB binding site (underscored),
76102
GAAAAATACTGG-GAATTCTCAATG Phosphatidylinositol 3-kinase assay
Cells were grown in 60-mm culture dishes overnight. Cells were treated with 100 mM 2-AAF for various lengths of time. Cells were harvested and whole cell lysates were prepared. PI3K assays were performed according to the procedure previously described (Reddy et al., 1997; Sizemore et al., 1999) . Brie¯y, activated PI3K was immunoprecipitated with anti-PY20 antibody/protein A-Sepharose. After several washes, the bound beads were subjected to the kinase assay using phosphatidylinositol (4,5)P 2 as substrate. [
32 P]phosphatidylinositol 3-phosphate was resolved by thin layer chromatography (Roya and Park, 1995) .
Rac activation assay
Activated Rac was assayed by measuring the formation of Rac-GTP according to the procedure described by Benard et al. (1999) using PAK-1 PBD agarose assay kit purchased from Upstate Biotechnology (Lake Placid, NY, USA).
Superoxidase production assay
Induction of superoxides by 2-AAF was determined according to the procedure described by De Mendez et al. (1994) . Brie¯y, 293 cells (0.5610 6 ) were suspended in 100 ml of Hank's balanced salt solution without Ca 2+ and Mg
2+
containing 150 mM ferricytochrome C and various concentrations of 2-AAF. A control reaction mixture containing 0.1 mg of superoxide dismutase (SOD) was processed in parallel. After incubation at 378C for 120 min, the absorbance of the cell suspensions at 550 mm was determined. Superoxide production was determined using extension coecient of 21 mM 71 cm 71 (De Mendez et al., 1994) .
Other procedures
The procedures used for extraction of total RNA, preparation of antisense RNA probes the RNase protection assay have been described previously . Preparations of nuclear extracts, assay of IKKb activation and transfection of recombinant plasmid DNA using lipofectamine (GIBCO/BRL, Rockville, MD, USA) followed the procedures described (Deng et al., 2001a) .
